UrgentRX

Denver, United States Founded: 2010 • Age: 16 yrs Acquired By Synergy CHC
Over-the-counter medications are delivered in portable powdered packets.
Annual revenue - Latest available
Total funding $28.8M 7 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About UrgentRX

UrgentRX is a company based in Denver (United States) founded in 2010 was acquired by Synergy CHC in November 2015. UrgentRX has raised $28.76 million across 7 funding rounds from investors including Synergy CHC and JUMP Investors.

  • Headquarter Denver, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $28.76 M (USD)

    in 7 rounds

  • Latest Funding Round
    $19.73 M (USD), Series C

    Jan 30, 2015

  • Investors
    Synergy CHC

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Synergy CHC

    (Nov 16, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of UrgentRX

Headcount 10-50
Employee Profiles 1
Employee Profiles
People
Jordan Eisenberg
Founder and CEO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of UrgentRX

UrgentRX has successfully raised a total of $28.76M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $19.73 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series C — $19.7M
  • First Round

    (24 Jun 2010)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2015 Amount Series C - UrgentRX Valuation

investors

Oct, 2013 Amount Series B - UrgentRX Valuation

investors

Apr, 2013 Amount Series B - UrgentRX Valuation

investors

Investors in UrgentRX

UrgentRX has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Synergy CHC and JUMP Investors.

All
Venture Fund
Investor Description Founded Year Domain Location
Early and growth-stage companies are funded by JUMP Investors.
Founded Year Domain Location
Health supplements and personal care products are manufactured and marketed.
Founded Year Domain Location

Investments & Acquisitions by UrgentRX

Investments

Financial Statements - UrgentRX

Urgentrx Comparisons

+
Add Comparison
Available on Premium

Competitors of UrgentRX

Latest news on Urgentrx

Frequently Asked Questions about UrgentRX

UrgentRX was founded in 2010.

UrgentRX is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

UrgentRX is a funded company, having raised a total of $28.76M across 7 funding rounds to date. The company's 1st funding round was a Series B of $2.5M, raised on Jun 24, 2010.

UrgentRx was founded in 2010 in Denver, United States, focusing on the healthcare sector. Over-the-counter remedies are offered in fast-dissolving powder form within single-dose, credit-card-sized packets for ease of use. Products address conditions such as heart attacks, headaches, aches, stomach issues, diarrhea, heartburn, and indigestion. The company was acquired by SynergyCHC in November 2015, enhancing distribution of these accessible medications.

UrgentRX has 2 investors. Key investors include Synergy CHC, and JUMP Investors.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available